Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHB2400346	复方氨基酸注射液（18AA-SF）		Injection	Chemical Drugs(原6)	Supplementary Application	2024-03-06		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2400345	复方氨基酸注射液（18AA-SF）		Injection	Chemical Drugs(原6)	Supplementary Application	2024-03-06		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2400266	复方氨基酸注射液(15-HBC-SF)		Injection	Chemical Drugs(原6)	Supplementary Application	2024-02-19		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2400265	复方氨基酸注射液(15-HBC-SF)		Injection	Chemical Drugs(原6)	Supplementary Application	2024-02-19		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2202291	复方氨基酸注射液（14AA-SF）		Injection	Chemical Drugs(原6)	Supplementary Application	2022-12-27		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2202292	复方氨基酸注射液（14AA-SF）		Injection	Chemical Drugs(原6)	Supplementary Application	2022-12-27		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2201413	复方氨基酸注射液（18AA-V-SF）		Injection	Chemical Drugs	Supplementary Application	2022-08-11		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2201414	复方氨基酸注射液(18AA-V-SF)		Injection	Chemical Drugs	Supplementary Application	2022-08-11		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2201415	复方氨基酸注射液(18AA-V-SF)		Injection	Chemical Drugs	Supplementary Application	2022-08-11		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2201114	复方氨基酸注射液（14AA-SF）		Injection	Chemical Drugs(原6)	Supplementary Application	2022-07-07		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2201115	复方氨基酸注射液（14AA-SF）		Injection	Chemical Drugs(原6)	Supplementary Application	2022-07-07		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2200056	复方氨基酸注射液（20AA）		Injection	Chemical Drugs(原6)	Supplementary Application	2022-01-11		Hubei Banbantian Pharmaceutical Co Ltd			view
CYHB2100190	复方氨基酸注射液（14AA-SF）		Injection	Chemical Drugs	Supplementary Application	2021-01-28	湖北一半天制药有限公司	Hubei Banbantian Pharmaceutical Co Ltd	Certificate Issued	2021-11-05	view
CYHB2100189	复方氨基酸注射液（14AA-SF）		Injection	Chemical Drugs	Supplementary Application	2021-01-28	湖北一半天制药有限公司	Hubei Banbantian Pharmaceutical Co Ltd	Certificate Issued	2021-11-05	view
CYHB2100193	复方氨基酸注射液(18AA-V-SF)		Injection	Chemical Drugs	Supplementary Application	2021-01-28	湖北一半天制药有限公司	Hubei Banbantian Pharmaceutical Co Ltd	Certificate Issued	2021-11-05	view
CYHB2100192	复方氨基酸注射液(18AA-V-SF)		Injection	Chemical Drugs	Supplementary Application	2021-01-28	湖北一半天制药有限公司	Hubei Banbantian Pharmaceutical Co Ltd	Certificate Issued	2021-11-05	view
CYHB2100191	复方氨基酸注射液(18AA-V-SF)		Injection	Chemical Drugs	Supplementary Application	2021-01-28	湖北一半天制药有限公司	Hubei Banbantian Pharmaceutical Co Ltd	Certificate Issued	2021-11-05	view
CYHB1707454	复方氨基酸注射液(18AA-V-SF)		Injection	Chemical Drugs	Supplementary Application	2018-03-14	湖北一半天制药有限公司	Hubei Banbantian Pharmaceutical Co Ltd	Certificate Issued	2018-08-17	view
CYHR1700038	奥沙利铂	oxaliplatin	Active ingredient	Chemical Drugs	State Standards	2017-07-17	湖北一半天制药有限公司	Hubei Banbantian Pharmaceutical Co Ltd	Certificate Issued	2017-12-21	view
CBHR1700008	盐酸吉西他滨	gemcitabine hydrochloride	Active ingredient	Chemical Drugs	State Standards	2017-05-18	湖北一半天制药有限公司	Hubei Banbantian Pharmaceutical Co Ltd	In Review	2018-10-29	view